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-most of which occur in a stressful mechanical milieu. To play such roles, platelets activate integrin α IIb β 3 to carry out adhesive and signalling functions [2] [3] [4] . Strikingly, platelets can rapidly sense and respond to haemodynamic forces to allow the mechanical environment to regulate their activation [4] [5] [6] [7] . Disturbed blood flows, as occur with vessel stenosis or medical device intervention, stimulate platelet adhesion and aggregation, and facilitate the formation and propagation of thrombi 8, 9 , thereby increasing the risk of occlusive thrombosis 10 . The ability of platelets to sense haemodynamic forces largely depends on the mechanosensing of integrin α IIb β 3 (refs. 9, 11 ) and glycoprotein Ibα (GPIbα) 5, [12] [13] [14] through engaged ligands such as fibrinogen (Fg), fibronectin and von Willebrand factor (VWF), although the detailed mechanisms remain incompletely understood.
Understanding how force stimulates platelet aggregation is clinically relevant, because the prothrombotic effects of disturbed blood flow cannot be eliminated by conventional antiplatelet agents that inhibit agonist-induced platelet aggregation mechanisms 8, 10 . However, whether the α IIb β 3 integrins are activated similarly or differently by biomechanical versus biochemical (agonists, such as adenosine diphosphate (ADP), thrombin and thromboxane A2 (TXA2)) stimuli is still elusive, hindering our understanding of the mechanisms underlying shear-induced thrombosis. Moreover, how GPIbα and α IIb β 3 interplay to coordinate platelet mechanosensing remains poorly defined.
Integrins are αβ heterodimers that have multiple states with distinct conformations and affinities. According to the switch-blade model 15 , inactive integrins are bent (B) with a closed headpiece (C) where the hybrid domain swings in; its ligand binding is undetectable unless using ultrasensitive techniques 16 . On activation, integrins may unbend to an extended-closed (EC) conformation, followed by headpiece opening with the hybrid domain swung out, resulting in an extended-open (EO) conformation 17, 18 (Fig. 1a) . Integrin α IIb β 3 can be activated bidirectionally, via inside-out signalling induced by GPIbα 19, 20 or soluble agonist receptors 4 , and via outside-in signalling, which requires ligand association 21 . The EO α IIb β 3 binds ligand with high affinity 17, 22 . In contrast, only standalone, unliganded EC α IIb β 3 is seen in crystal structures 23 , and is hypothesized to have low affinity, similar to its BC conformer 24 . Nonetheless, whether EC α IIb β 3 exists physiologically (and its function and regulation) remains unclear.
By using our recently developed dual biomembrane force probe (dBFP) 20 and fluorescence biomembrane force probe (fBFP) 13 combined with microfluidic perfusion assays, we identified an intermediate affinity state of α IIb β 3 in the EC conformation, which exists in-and is critical to-the development of biomechanical platelet aggregation. Furthermore, our work mapped the activation landscape of integrin α IIb β 3 on live platelets and elucidated different mechanisms of α IIb β 3 activation in the development of biomechanical and biochemical thrombi.
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NaTUre MaTerIals aggregation, we perfused human whole blood through a microfluidic channel with a two-dimensional (2D) hump mimicking stenosis (Fig. 1b) 8, 25 . Amplification loop blockers (ALBs) were added to inhibit platelet activation by soluble agonists 26 . To define the α IIb β 3 conformation and activation states, we used confocal microscopy to visualize real-time immunostaining of developing platelet aggregates by monoclonal antibodies (mAbs) (Fig. 1a) . MBC370.2 recognizes a motif on the α IIb Calf-1 domain that is only accessible on extended integrins 27 . AP5 recognizes an epitope in the β 3 plexinsemaphorin-integrin (PSI) domain and reports hybrid domain swing-out 28 . Therefore, combined MBC370. + ). PAC-1 binds the high-affinity form of the α IIb β 3 ligand-binding site 29 .
As a control, SZ22 stains all α IIb β 3 conformations 30 .
Platelets primarily aggregated downstream of the hump, which positively stained with MBC370.2 but not AP5 or PAC-1 ( Fig. 1c and Supplementary Videos 1-3). MBC370.2 staining requires stenosis shear stimulation, because it stained negative in the static condition ( Supplementary Fig. 1 ).
To compare these results with biochemical platelet aggregation, we injected ADP (Fig. 1d) or thrombin receptor-activating peptide (TRAP) ( Supplementary Fig. 2 ) 2 min after platelet aggregate formation. The chase of agonists rapidly increased the rate and extent of platelet aggregation, leading to channel occlusion, and generated extensive staining of MBC370.2, AP5 and PAC-1 (Supplementary In the EO integrin, the oval notch spanning parts of the βI and β-propeller domains indicates the high-affinity ligand binding state recognizable by PAC-1. The binding sites for α IIb β 3 conformation-dependent (MBC370.2, AP5, PAC-1) and -independent (SZ22) monoclonal antibodies (mAbs) are indicated. b, Biomechanical platelet aggregation model showing the dimensions of the microfluidic channel, in-built stenosis hump and platelet accumulation and imaging area (dashed box). c,d, Blood was mixed with SZ22-Alexa488 and either MBC370.2-, AP5-or PAC-1-Alexa647, and perfused through the microfluidic channels at 1,800 s −1 bulk shear rate for 10 min. Differential interference contrast (DIC) and confocal images were taken to show platelet aggregates and mAb binding (1st column, merge; 2nd column, SZ22; 3rd column, MBC370.2; top, MBC370.2; middle, AP5; bottom, PAC-1). Biomechanical (c) or biochemical (d) platelet aggregations were induced by treating blood with amplification loop blockers (ALBs) (c) or without ALB but adding 50 µM ADP 2 min after platelets started to aggregate on the stenosis downstream (d). Images are representatives of ≥3 independent experiments of different human donors in duplicate. Scale bars, 10 μm. e, Quantitation of α IIb β 3 reporter mAb binding (intensity ratio of reporter mAb over SZ22) following biomechanical and biochemical stimulations. Data are presented as median ± 25th/75th percentile and min/max values (from left to right, n = 7, 7, 8, 14, 7, 7, 8, 7, 8) . NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001, assessed by unpaired t-test with Welch's correction. f-h, Mean ± s.e.m. of SZ22 + and MBC370.2 + areas on platelet aggregates at indicated perfusion times without (h) or with 50 μg ml −1 ALMA12 (f) or 20 μg ml −1 Abciximab (g).
NaTUre MaTerIals . The ADP-and TRAP-stimulated platelet aggregates displayed MBC370.2 staining comparable to biomechanically induced platelet aggregates, while AP5 and PAC-1 displayed much higher staining (all normalized by SZ22 staining) (Fig. 1e) . Thus, on biomechanical platelet aggregates, a large portion of α IIb β 3 molecules were EC and PAC-1 non-recognizable (PAC-1 − EC), whereas on biochemical platelet aggregates, many integrins were PAC-1 + EO. Corroborating this observation, a β 3 integrin extension reporter, MBC319.4 27 , rendered similar staining as MBC370.2 ( Supplementary Fig. 3 ).
Blocking GPIbα eliminated platelet aggregation (Fig. 1f,g and Supplementary Fig. 4a ) 8 , whereas blocking α IIb β 3 severely limited platelets from forming large and stable aggregates, notwithstanding the remaining platelets still stained with MBC370.2 (Fig. 1f,h and Supplementary Fig. 4b ). Extending our previous discovery 8 , these data indicate that biomechanical platelet aggregation is initiated by GPIbα and depends on α IIb β 3 with an EC conformation.
GPIbα mechanosignalling activates α IIb β 3 to the EC conformation. To examine the GPIbα requirement of α IIb β 3 extension, we used a dBFP adhesion frequency assay 20 to interrogate the interplay between GPIbα and α IIb β 3 on a single platelet. Probe I of the dBFP was functionalized with a recombinant VWF-A1 domain 31 , which binds GPIbα but not α IIb β 3 (ref. 32 ); probe II was functionalized with a α IIb β 3 reporter mAb (Fig. 2a,b) . We previously demonstrated that a single GPIbα-A1 bond that sustains a 25-pN tensile Scale bars, 2 μm. c, Adhesion frequency of the indicated mAbs (median ± 25th/75th percentile and min/max, n = 12) to platelets that were either unstimulated (Uns.) or stimulated by A1 (>2 s lifetime event at 25 pN) or ADP (50 μM, 15 min). d, Number of captured platelets per area of surface cofunctionalized with A1 and the indicated mAbs (median ± 25th/75th percentile and min/max; n = 8, 9, 12, 9, 9, 12, 11, 11, 10, 13, 11, 13, 9, 10, 9, 11) of washed platelets perfused at 4 dynes cm
. For each mAb, statistical comparisons in c and d were made between the current and leftmost conditions, Uns. in c and 6D1
+

ADP
− in d, unless otherwise specified. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, assessed by unpaired, two-tailed Student's t-test. e, Integrin modelled mechanically as a spring under pulling, which has a smaller or larger spring constant, k mol , when it is bent (left) or extended (right). f-h, Histograms (bars) and single (f), dual (g) or triple (h) Gaussian fits (thin curves) to the first (left), second (middle) and third (right) sub-populations, and overall fits to the whole populations (colour-matched thick curves) of 160, 181 and 193 k mol measurements, respectively, on unstimulated (f), A1-stimulated (g) and ADP-stimulated (h) platelets pulled by FN (at ~20% adhesion frequency to ensure mostly single bonds). Portions of some curves are obscured due to overlapping. Goodness-of-fit (R 2 ) and the fitted mean k mol and fraction of each sub-population are indicated. 10 µg ml Articles NaTUre MaTerIals force for >2 s is sufficient to trigger robust intraplatelet calcium 13 and upregulate α IIb β 3 (ref. 20 ). Therefore, we drove a micropipetteaspirated platelet to repeatedly touch probe I and retract to clamp at 25 pN. Once a >2 s lifetime event was observed ( Supplementary  Fig. 5a ), the platelet was realigned to probe II to assess the resulting α IIb β 3 changes.
A1-stimulated platelets showed substantial binding to MBC370.2 and to another 'E'-conformation reporter, LIBS-2 (anti-β 3 ) 33 , but not to AP5 or PAC-1, indicating that GPIbα mechanosignalling induces PAC-1 − EC α IIb β 3 . In contrast, unstimulated platelets only adhered to the conformation-independent mAbs SZ22 and HIP8
34
; ADPstimulated platelets adhered to all six mAbs at high frequencies (Fig. 2c) . Thus, the same α IIb β 3 conformational changes were observed in the dBFP experiments as in the stenosis perfusion experiments, regardless of how such conformational changes were induced (mechanically or chemically).
The above results were confirmed by perfusing washed platelets through a microfluidic chamber co-functionalized with A1 and one of the mAbs (Fig. 2d) . Platelet adhesion to A1/HIP8 and A1/LIBS-2 was high, but much lower to A1/AP5 and A1/PAC-1, which were significantly increased by ADP pre-treatment. Blocking GPIbα with 6D1 moderately decreased platelet adhesion on A1/HIP8, suggesting a minor contribution of the GPIbα-A1 interaction to physically linking platelets and the surface, but significantly reduced platelet adhesion on A1/LIBS-2, suggesting a crucial role for the GPIbα-A1 interaction in inducing α IIb β 3 extension.
Assessing integrin conformation by molecular stiffness. Force applied via an engaged ligand can lengthen the head-to-tail distance of an integrin because it behaves like a spring 35 . The integrin stiffness depends on its conformation, as extended integrins are stiffer than bent integrins 35 ( Fig. 2e) . We coated the dBFP probe II with a low density of fibronectin module III domains 7-10 (abbreviated as FN) to pull α II β 3 for stiffness measurements of one integrin per adhesion event 36 . On resting platelets, the measurements produced a single-Gaussian histogram (Fig. 2f) , which serves as benchmark stiffness for the BC integrins. After A1 stimulation by probe I, the integrin stiffness histogram exhibited a broader shoulder on the right side of the peak, which is better fitted (see Methods and Supplementary Table 1 ) by a dual-rather than a single-Gaussian distribution (Fig. 2g) . The first Gaussian matched the BC α II β 3 stiffness in Fig. 2f , while the second sub-population displayed a higher stiffness, suggesting the EC conformation. In contrast, the stiffness from ADP-stimulated platelets adopted a triple-Gaussian distribution (Supplementary Table 1 and Fig. 2h ). The first two sub-populations matched the stiffness of BC and EC α II β 3 molecules, while the third sub-population was probably contributed by EO α II β 3 , with the further increased stiffness possibly resulting from headpiece opening. Overall, our molecular stiffness measurements agree with the mAb mapping results. As a control, Mn 2+ activation resulted in two sub-populations matching the stiffness of BC and EO, but not EC α II β 3 ( Supplementary Fig. 5b ).
EC α IIb β 3 binds ligands with an intermediate affinity. To characterize the ligand binding of EC α IIb β 3 , we measured the platelet adhesion frequency (P a ) to FN by dBFP. P a was increased from 5% of resting platelets by A1 stimulation to 30%, which was further increased by ADP or thrombin to 70-80% (Fig. 3a) . Chelating intracellular Ca 2+ resulted in a lower P a , whereas chelating extracellular Ca 2+ had no effect ( Supplementary Fig. 5c and Fig. 3a) , confirming that GPIbα mechanosignalling requires intracellular but not extracellular calcium 5, 6 . . NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, assessed by unpaired, two-tailed Student's t-test.
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FN binds three platelet integrins with expression levels α IIb β 3 ≫ α V β 3 ≈ α 5 β 1 , all contributing to platelet adhesion [37] [38] [39] . To dissect the relative contributions of the three integrins to the measured P a , we calculated the average number of total bonds bridging the platelet and the FN-bearing bead 36 , <n> total = −ln(1 − P a ). On blocking α V β 3 with LM609 40 or α IIb β 3 with 10E5
41
, we measured the remaining P a and calculated the <n> total-αVβ3 and <n> total-αIIbβ3 ('−' meaning 'minus'). After normalizing by the ligand density (m l ), we found <n> total-αVβ3 /m l + <n> total-αIIbβ3 /m l indistinguishable from <n> total /m l for resting, A1-stimulated and ADP-stimulated platelets ( Fig. 3b and Supplementary Table 2c ). This suggests that the total bonds were primarily contributed by α IIb β 3 and α V β 3 , which bind FN concurrently and independently 42 , whereas α 5 β 1 has negligible contribution, a conclusion confirmed by a β 3 -inhibitor, integrilin 43 , which eliminated all FN binding to the basal level ( Supplementary Fig. 5c ).
We next divided the <n>/m l values by the surface densities of α IIb β 3 or α V β 3 (m r ) to calculate their average 2D effective affinities 36 , <A c K a >. Three levels of <A c K a > αIIbβ3 were observed on resting, A1-stimulated and ADP-stimulated platelets (Fig. 3c) . Considering A1 stimulation induces a subset of EC α IIb β 3 integrins, the higher <A c K a > αIIbβ3 on A1-stimulated than resting platelets is attributed to a higher affinity of the EC α IIb β 3 . A1-and ADP-stimulated platelets bound to 'E'-reporter mAbs at similar levels ( Fig. 2c,d ), indicating comparable surface densities of extended α IIb β 3 molecules (all EC on A1-stimulated and an EC/EO mixture on ADP-stimulated platelets). The higher <A c K a > αIIbβ3 on ADP-stimulated than A1-stimulated platelets should therefore be attributed to a higher affinity of the EO than EC α IIb β 3 . As a control, 0.5 mM Mn 2+ elevated the <A c K a > αIIbβ3 similar to A1 stimulation (Fig. 3c) .
Using the same strategy, we found that platelet binding to Fg was also mediated by α IIb β 3 and α V β 3 (Fig. 3d ,e and Supplementary  Fig. 5c ). Three levels of <A c K a > αIIbβ3 were again observed on resting, A1-stimulated and ADP-stimulated platelets (Fig. 3c) . Resting platelets have a much higher <A c K a > αIIbβ3 for Fg than FN, agreeing with the previous reports that α IIb β 3 modulates resting platelet attachment to immobilized Fg but not fibronectin 44 , probably because of the distinct primary binding motifs (AGDV versus RGD) of the two ligands. The consistent results from two ligands demonstrate a hierarchy of affinities for the three α IIb β 3 conformations: BC < EC < EO.
EC α IIb β 3 dissociates from ligands with an intermediate rate.
Dissociation rate under force is an important property of the receptor-ligand interaction orthogonal to affinity. We used dBFP to measure single α IIb β 3 -FN bond lifetimes-the reciprocal of dissociation rates (Fig. 4a) . Resting platelets yielded a slip bond where the average lifetime decreased with force 45 . A1-stimulated platelets elicited a catch bond below 6.5 pN where the average lifetime increased with force 45 , which turned into a slip bond over an extended force range; 
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NaTUre MaTerIals the average lifetimes were also longer across all forces. ADP stimulation greatly broadened the catch bond force regime, and further prolonged the lifetimes. Thus, the lifetimes of A1-stimulated platelets are between resting and ADP-stimulated platelets, correlating with the EC α IIb β 3 . Changing the ligand to Fg also yielded three average lifetime curves that exhibit catch bonds (Fig. 4b) , in contrast to the previous slip bond reports of purified α IIb β 3 -Fg interactions 46, 47 , suggesting an impact of the cellular environment. Together, these data demonstrate a hierarchy of force-dependent bond lifetimes for the three α IIb β 3 conformations: BC < EC < EO.
Notably, the GPIbα mechanosignalling-induced intermediate state is specific for α IIb β 3 . Although α V β 3 can be activated by ADP 38, 48 , it was unresponsive to GPIbα mechanosignalling ( Fig. 3f and Supplementary Fig. 6a-e) . Platelet α 5 β 1 could be activated by activating mAb TS2/16 or Mn 2+ to bind FN, but not by A1 or ADP stimulation ( Supplementary Fig. 6f ).
Besides binding to GPIbα, full-length VWF also binds α IIb β 3 via the RGD moiety. We found that GPIbα mechanosignalling is still the prerequisite for α IIb β 3 to be intermediately activated for VWF binding (Supplemental Note 1).
Altogether, our results define an intermediate state for α IIb β 3 that features an EC conformation, intermediate ligand binding affinity and bond lifetime, distinguishing itself from the inactive and active states that respectively adopt the BC and EO conformations, low and high ligand binding affinities, and short and long bond lifetimes (Fig. 4c) .
Distinct α IIb β 3 responses to different inside-out signals.
Platelets stimulated by 2-µM ADP bound FN with a similar P a as A1-stimulated platelets (Fig. 3a) , but their lifetime curve was indistinguishable from that of 50 µM ADP-stimulated platelets (Fig. 4a) , suggesting that low-dose ADP activates α IIb β 3 in a different manner to A1. To further verify that mechanical and chemical stimulations (Fig. 5a ) induce distinct α IIb β 3 inside-out signaling, we measured the platelet dose-response to A1 and ADP stimulations using three complementary assays (all statistical analysis results are summarized in Supplementary Table 3) . We define the 'dose' of a mechanical stimulation as the amount/intensity of its mechanical effect.
We first used the dBFP to switch a platelet from an A1 probe to a FN or Fg probe to measure the α IIb β 3 adhesion frequency after the first GPIbα-A1 lifetime event, regardless of its duration. The postswitch P a was found to initially increase with the A1 lifetime, indicating a mechanical dose dependency of α IIb β 3 activation (Fig. 5b) . The P a then plateaued after 2 s and stayed unchanged for up to 60 s, confirming that the intermediate affinity was not due to insufficient mechanical stimulation. Replacing the ligands with MBC370.2 yielded similar results; by comparison, the P a to SZ22 was constantly high and those to AP5 and PAC-1 were at background levels, showing no dose dependency (Fig. 5c) .
We next employed a cone-and-plate rheometer to apply varied shear rates (0-10,000 s ) to platelets mixed with dimeric VWF-A1 (dA1), which crosslinked GPIbα on two platelets and exerted forces on them. The resulting α IIb β 3 activation was examined by flow cytometry with reporter mAbs. While the majority of platelets remained singlets ( Supplementary Fig. 7a ), the fraction of platelets positively stained by MBC370.2, but not AP5 or PAC-1, increased significantly with shear ( Supplementary Fig. 7b-f and Fig. 5d ), indicating a mechanical dose dependency of the PAC-1 − EC α IIb β 3 population. In contrast, stimulation of ADP from 0.01 to 10 μM without shearing increased staining of all three reporter mAbs with statistically similar trends (Fig. 5e) , indicating a dose-dependent increase of the PAC-1 + EO α IIb β 3 population. We then used a 'zoning' microfluidic chamber that recapitulates the dBFP switch assay in a high-throughput manner. FN, A1 and an α IIb β 3 reporter mAb were micropatterned in three spatially adjacent zones (Fig. 5f) . A platelet suspension was perfused first through the FN zone to confirm their unadherent resting state. The platelets then translocated on and were stimulated by the A1 zone, the length of which varied on different devices, providing adjustable doses of mechanical stimulation to platelets. Subsequently, platelets entered the mAb zone to report the α IIb β 3 status. The number of captured platelets on MBC370.2 initially increased with the A1 zone length and plateaued at 400 µm, whereas platelet capturing on SZ22 was uniformly high and on AP5 and PAC-1 uniformly low (Fig. 5g) . In contrast, adhesion of ADP-stimulated platelets in a single-zone flow chamber to surfaces coated with MBC370.2, AP5 or PAC-1, but not SZ22, all increased dose-dependently (Fig. 5h) .
The above three assays consistently demonstrated distinctive dose dependencies of α IIb β 3 activation on mechanical and chemical stimuli: GPIbα mechanosignalling only upregulated α IIb β 3 to the intermediate state, whereas ADP evoked the emergence of active α IIb β 3 even at low doses. These different activation outcomes indicate distinct underlying signalling mechanisms.
Distinct signals following mechanical and chemical stimulations.
The distinction in signalling mechanisms was further demonstrated by fBFP 13 , showing distinctive intraplatelet Ca 2+ patterns (transient versus sustained) in A1-and ADP-stimulated platelets (Fig. 5i ) 5, 6 . Importantly, ADP-but not A1-triggered Ca 2+ was suppressed by EGTA ( Fig. 5i-k : extracellular Ca 2+ influx was involved during ADP stimulation, whereas A1 stimulation only triggered internal storage release 5, 6 .
From intermediate state to mechanical affinity maturation.
We used the dBFP to study the interplay of integrin inside-out and outside-in signalling. After a >2-s A1 lifetime event, we measured post-switch α IIb β 3 -FN and α IIb β 3 -Fg binding over a prolonged time, which exerted repetitive intermittent mechanical stimulations to the integrins and monitored their binding changes concurrently. Remarkably, the binding frequency displayed a sigmoidal time course, with the corresponding <A c K a > plateauing at a level similar to that of ADP-stimulated platelets (Fig. 6a-c) , suggesting integrin affinity maturation. This gradual elevation of integrin activity was not due to a delayed response to GPIbα mechanosignalling, because prolonging the A1-to-FN switch time interval yielded a gradual decay in the integrin activity ( Supplementary Fig. 8a ). Repeated pulling on integrins also triggered strong and sustained intraplatelet platelet Ca 2+ (Fig. 6d-f) , the onset of which preceded integrin affinity maturation (Fig. 6a) . No binding increase was observed when extracellular Ca 2+ was chelated to eliminate Ca 2+ influx ( Fig. 6d-f ) or when the platelet was touched continuously with a ligand-coated bead to allow bond formation and dissociation at zero force for 5 min but without pulling (Fig. 6a,b) . These data indicate that the affinity maturation requires both force on α IIb β 3 and extracellular Ca 2+ influx 5, 6 and rule out the contribution of ligand 'priming'-induced integrin activation, which requires neither force nor cellular signalling 17, 49 . The requirement of sequential GPIbα and α IIb β 3 mechanosignalling underscores the mechanical nature of this affinity maturation process. The results also reveal the transient nature of the intermediate state in the absence of sufficient stimulation.
Both the initial FN binding and its subsequent elevation over repetitive touches were suppressed by pre-treating platelets with BAPTA-AM, prolonging the A1-to-FN switch time interval or shortening the A1 lifetime ( Fig. 6a and Supplementary Fig. 8 ). Without A1 pre-stimulation, α IIb β 3 remained at the low activity level indicative of the resting state (Fig. 6a-c) and did not trigger any Ca 2+ above the baseline throughout the repetitive FN touches (Fig. 6d-f ). These data indicate that the GPIbα mechanosignalling that upregulates α IIb β 3 to the intermediate state is a prerequisite for its mechanical affinity maturation. 's t-test; n = 13, 17, 15, 11, 9) . NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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To measure the α IIb β 3 lifetimes and molecular stiffness after mechanical affinity maturation (>100 cycles), the contact time was shortened to 0.1 s to lower the adhesion frequency to ~20% (cf. Supplementary Fig. 9a ). The lifetime curves were comparable to those of ADP-stimulated platelets (Fig. 6g,h) ; however, 70.7% and 18.5% of the bonds displayed stiffness values matching EC and EO α IIb β 3 ( Fig. 6i and Supplementary Table 1) . These indicate that after mechanical affinity maturation, intermediate state α IIb β 3 still dominates ligand binding, yet a small fraction of integrins adopt the active state to prolong bond lifetimes. Such a composition of α IIb β 3 conformers should represent most of the platelets in biomechanical platelet aggregates (Fig. 1c) , where both GPIbα and α IIb β 3 are engaged with ligands. Without extracellular Ca 2+ or A1 pre-stimulation, the α IIb β 3 either returned to the inactive state or remained inactive despite repetitive ligand pulling (Fig. 6g,h,j,k) . , fitted mean k mol and fraction of each sub-population are indicated. LM609 was added in all experiments. NS, not significant; **P < 0.01; ***P < 0.001, assessed by unpaired, two-tailed Student's t-test.
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Discussion
Our findings regarding the conformation-function relationship of integrin can be summarized in a model of α IIb β 3 activation and mechanosensing as related to platelet aggregation ( Supplementary  Fig. 10 Due to the lack of relayed coupling between the αI-βI domains, αI-absent integrins were hypothesized to be unable to have a higher affinity in the EC than BC conformation 18, 24 . We observed sustained expression of EC α IIb β 3 on live platelets that displayed intermediate affinity and bond lifetimes, demonstrating that EC α IIb β 3 is not merely a functionally 'inert' state on the path of transitioning towards the EO conformation 17, 23, 50 . Interestingly, PAC-1 does not report α IIb β 3 intermediate activation (Supplementary Note 2) .
Integrin affinity maturation describes the progression of integrin activation from the low to high affinity state. We have shown that, without forming a cluster of integrin-ligand bonds (for example, in focal adhesions), repetitive and intermittent ramp forces on single intermediate (but not inactive) state α IIb β 3 trigger mechanical outside-in signalling, resulting in affinity maturation. This extends our understanding of integrin-mediated mechanosensing [51] [52] [53] [54] . The sequential GPIbα and α IIb β 3 mechanosignalling defines a mechanical pathway of integrin affinity maturation, where the integrin binding propensity increases with a continuing mechanical stimulation, which is different from the biochemical activation of α IIb β 3 by soluble agonists and also from the reported affinity maturation in integrin α L β 2 on T lymphocytes produced by combined soluble agonist stimulation and immobilized-ligand binding 55 . Our data also suggest an 'on/off ' switch of α IIb β 3 outside-in signalling: it will be switched 'on' only after α IIb β 3 adopts the intermediate state; otherwise, it remains 'off ' .
Biomechanical platelet thrombi formed in stenosed blood vessels were observed in multiple arterial injury models under disturbed blood flow 8 , primarily governed by the GPIbα-α IIb β 3 axis 5, 6, 19 . Considering the importance of mechanosignalling in varied stages of thrombus development (Supplementary Note 3), our findings that biomechanical thrombus growth is mainly mediated by intermediate state α IIb β 3 triggered by a biomechanical activation pathway will probably guide the future development of new anti-thrombotic strategies.
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Methods
Proteins, antibodies and reagents. Biotinylated FN was obtained from A. Garcia (Georgia Tech). Recombinant monomeric and dimeric VWF 1208-A1 (residues A0742-17/21) 56 were from Z. Ruggeri (The Scripps Research Institute). Human fibrinogen was purified from freshly frozen plasma using a described method 57 . Integrilin or eptifibatide was from Millenium Pharmaceuticals. mAbs 10E5 and 6D1 were from B. Coller (Rockefeller University), and AP5 was from P. Newman (BloodCenter of Wisconsin). ALMA12 was from F. Lanza (INSERM U.311), HIP8-FITC, PAC-1 and an isotype control (H57 anti-mouse TCRβ) from BD Biosciences, LM609, ab62 (LIBS-2) and P1D6 from EMD Millipore, TS2/16 and unlabelled HIP8 from Thermo Fisher Scientific, SZ22 from Beckman Coulter, MBC319.4 and MBC370.2 27, 58 from Kerafast, PAC-1-Alexa647 from BioLegend, Abciximab (c7E3 Fab) from Eli Lilly, HFN 7.1 from Abcam, 1D6 from Santa Cruz Biotechnology and PE-conjugated polyclonal anti-mouse antibody from eBioscience. Conjugation of some mAbs with Alexa488 or Alexa647 was done using a Zenon Labeling Kit following the manufacturer's instructions (Thermo Fisher Scientific).
Thrombin receptor activator peptide (TRAP-6; SFLLRN, 4017752) was obtained from Bachem. Hirudin (Refludan) was from Pharmion/Celgene. Fura2-AM was from Thermo Fisher Scientific. ADP, thrombin, nystatin, streptavidin-maleimide (SA-MAL), dimethyl sulfoxide, apyrase, theophylline, clexane and BSA were from Sigma-Aldrich. MAL-PEG3500-NHS and biotin-PEG3500-NHS were from JenKem. Borosilicate glass beads were from Distrilab Particle Technology. All other reagents were from Sigma-Aldrich unless stated otherwise.
Blood collection and platelet isolation and preparation. All procedures involving the collection of blood from healthy donors were approved by the University of Sydney Human Research Ethics Committee (HREC, project 2014/244) and the Institutional Review Board of the Georgia Institute of Technology (protocol no. H12354). All human donor blood samples were obtained with written informed consent. Blood was slowly drawn from the vein of a healthy volunteer. For whole blood perfusion studies, blood was anticoagulated with hirudin (800 U ml
−1
). For platelet isolation, blood was drawn to fill a 3 ml syringe preloaded with 0.43 ml 7×ACD buffer (85 mM sodium citrate, 72.9 mM citric acid anhidrous, 110 mM d-glucose and 70 mM theophylline, pH 4.6). Whole blood was transferred into a 15 ml tube pre-loaded with apyrase (0.005 U ml ). After resting for 15 min at 37 °C, whole blood was centrifuged at 200g for 10 min without brake. Platelet-rich plasma was extracted, allowed to rest for 10 min at 37 °C, and centrifuged at 1,700g for another 5 min. The platelet pellet was resuspended in platelet washing buffer (4.3 mM K 2 HPO 4 , 4.3 mM Na 2 HPO 4 , 24.3 mM NaH 2 PO 4 , 113 mM NaCl, 5.5 mM d-glucose, 10 mM theophylline and 1% BSA, pH 6.5) preadded with clexane (20 U ml −1 ) and apyrase (0.01 U ml −1 ), rested for 10 min and centrifuged again at 1,500g for 5 min. The platelet pellet was resuspended into Hepes-Tyrode buffer (134 mM NaCl, 12 mM NaHCO 3 , 2.9 mM KCl, 0.34 mM sodium phosphate monobasic, 5 mM HEPES and 5 mM glucose, 1% BSA, pH 7.4) pre-added with apyrase (0.02 U ml ) with a platelet count of 3 × 10 8 ml −1 , read from a Sysmex KX-21N haematology analyser, and placed in a 37 °C water bath for 30 min before use. For activation by ADP or thrombin in BFP or flow chamber experiments, the platelet suspension was incubated with ADP or thrombin for 15 min before experiment.
Whole blood perfusion through stenosis microfluidic channels. A PDMS microfluidic channel incorporating a 85° degree fixed micro-contraction geometry (Fig. 1b) was designed to mimic haemodynamics in vivo with severe stenosis (80%) as previously described 8, 25, 59 . This geometry exposes platelets to well-defined spatial shear gradients that induce aggregation. The dimensions of the channel in its straight section are 100 μm (width) × 130 μm (height).
Hirudinated (800 U ml
) whole blood was first incubated with the conformation-independent mAb (SZ22-Alexa488) and an α IIb β 3 reporter Ab (MBC370.2-, AP5-or PAC-1-Alexa647, 1 μg ml was chosen to produce a bulk shear rate of 1,800 s −1 to mimic the blood flow in small arteries/arterioles 8 . Blood was introduced via a 200 μl reservoir cut into the PDMS block at the channel inlet, and flow was induced with a single syringe connected to the outlet and withdrawn by a PHD ULTRA pump (Harvard Apparatus). Platelet aggregation was monitored with combined dual-colour confocal microscopy with concurrent DIC imaging (Nikon A1R confocal microscope with a ×40 objective). Fluorescent images were captured using NIS software, version 4 (Nikon). Blood flow was observed within a focal plane approximately 30 μm above the coverslip bottom of the channels. Fluorescently labelled platelet aggregates were quantitatively analysed on a frame-by-frame basis off-line using ImageJ 1.50a (Fiji). To determine the region of global and activated platelet aggregates, the SZ22-Alexa488 and MBC370.2-Alexa647 channels were subject to respective intensity thresholding. To quantitate the integrin activation status, the staining intensities of SZ22, MBC319.4, MBC370.2, AP5 or PAC-1 in the 647 channel were measured in the same SZ22 thresholded region to calculate the intensity ratio.
To isolate the mechanical effects of blood flow from agonist-induced platelet activation, we performed experiments involving mechanical stimulations in the presence of the canonical platelet ALBs as previously described 8, 25 : apyrase (1 U ml −1 ), MRS2179 (100 mM) and 2-MeSAMP (10 mM) to block ADP; indomethacin (10 µM) to block TXA2 and hirudin (800 U ml −1 to block thrombin. To investigate the agonist-induced platelet activation, ADP (50 µM) or TRAP (500 µM) was injected to the microfluidic channel after 5 min perfusion of untreated whole blood.
In certain experiments, ALAM12 mAb (50 μg ml
) or Abciximab (20 μg ml −1 ) was added to block platelet GPIbα or α IIb β 3 bindings, respectively.
Red blood cell and glass bead preparation for BFP experiments. Blood collections followed the protocol approved by the Institutional Review Board of the Georgia Institute of Technology after written informed consent was obtained from subjects. Samples (8-10 μl) of human blood were collected from finger prick and centrifuged to isolate red blood cells (RBCs). RBCs were biotinylated by incubating with biotin-PEG3500-NHS (JenKem) solution 60 and partially swollen for BFP assembly by incubation with nystatin (Sigma-Aldrich).
The protocol for bead functionalization has been described elsewhere 60 . Glass beads (Distrilab Particle Technology) were first thiolated. To make FN beads, the thiolated glass beads were incubated first with SA-MAL overnight, then biotinylated FN for 3 h. The 0.1×, 3×, 20× and 100× FN beads were made by adjusting the FN incubation concentration to 0.1-fold, 3-fold, 20-fold or 100-fold, respectively. To make Fg, mA1, LIBS-2, HIP8, PAC-1 or AP5 beads, the protein was first mixed and incubated with MAL-PEG3500-NHS (JenKem) for 30 min (refs. 31, 61 ). The mixture was then incubated with the thiolated glass beads overnight. Beads were washed with and resuspended in phosphate buffer (27.6 g l BFP set-ups, experiment modes and related assays. Our first-generation BFP setup and operation are described in ref. 60 . Briefly, in an experimental chamber filled with Hepes-Tyrode buffer, a biotinylated RBC was aspirated by a micropipette with a probe bead attached to its apex via a SA-biotin interaction, which forms a force transducer (Fig. 2a,b) . The bead was functionalized with proteins of interest to interact with the receptors on the platelet aspirated by an opposing micropipette (Fig. 2a,b) , which was driven by a piezoelectric translator (Physik Instrumente) to move with nanometre resolution. The horizontal position of the probe bead was tracked by a high-speed camera, which reflected the RBC axial deformation and, by calculation, the platelet-bead force. The BFP spring constant k, determined using Evans' model 62 , was set to 0.3 or 0.25 pN nm −1 for clamping forces higher or lower than 10 pN, respectively, by adjusting the aspirating pressure based on the measured diameters of the micropipette, spherical portion of the RBC and RBC-bead contact area. Experimental data were collected and analysed by LabView (National Instruments). In the experimental chamber, 1 mM Ca 2+ /Mg 2+ or 1 mM Mg 2+ /EGTA was added to provide or eliminate extracellular Ca 2+ while maintaining integrin binding capability. In some experiments, ADP, thrombin or 0.5 mM Mn 2+ was added to activate the platelet integrins. For experiments that did not activate the platelets, apyrase with a final concentration of 0.02 U ml −1 was added into the experimental chamber to chelate ADP released from the platelets.
Force-clamp mode and bond lifetime assay. Force-clamp mode was used to measure single receptor-ligand bond lifetimes under a range of constant forces. The probe bead ligand coating density was adjusted to keep the adhesion infrequent (<20%) to satisfy the necessary condition for most of the adhesions (>89%) to be single bond events 63 . The platelet was driven to contact and impinge the probe bead, and then retracted at 3 µm s −1
. When binding was detected during retraction, the target pipette was held at a preset force to wait for bond dissociation, and returned to the original position to start the next cycle ( Supplementary Fig. 5a, trace 3) . Lifetime was defined as the duration of the clamping phase before bond dissociation. Lifetime data were binned according to the clamp forces. The forces and lifetimes in each bin were then averaged to plot the lifetime versus force curve.
In most platelet-FN lifetime measurements, FN was captured via its C-terminal biotin by wild-type (WT) tetravalent SA onto the BFP bead 64 . To exclude the possibility of multimeric bonds between up to four FN molecules captured by one SA and potential α IIb β 3 clusters, mutant monovalent SA was used in some experiments as a control 64 , which resulted in indistinguishable α IIb β 3 -FN bond lifetimes under A1-and ADP-stimulated conditions (Fig. 4a) . Because the higher the bond number the longer the lifetime 45 , the data indicate that the multimericbond effect was negligible using the WT SA.
Force-ramp mode and adhesion frequency assay. Force-ramp mode was used to detect the occurrence of adhesions at the end of a preset contact time for adhesion frequency assay, which allows for measurement of 2D receptor-ligand binding kinetics 36 . In a test cycle, the platelet approached and contacted the probe bead and retracted. A tensile force signal following retraction reported an adhesion event ( Supplementary Fig. 5a , trace 2) between the platelet and the bead, while the compressive force directly returning to zero indicated a no-adhesion event ( Supplementary Fig. 5a, trace 1) . The approach-contact-retraction cycle was repeated 30 times for three cell-bead pairs. The numbers of no-adhesion and adhesion events were enumerated to render a mean ± s.e.m. of adhesion frequency (P a ). Adhesion frequencies measured over a range of contact times contain Articles NaTUre MaTerIals information on both binding affinity and kinetics, whereas those measured for sufficiently long contact time (5 s) contain affinity information as bond formation and dissociation have reached a dynamic equilibrium 36 . The 5 s contact time was used to measure integrin-ligand binding affinities (Figs. 3 and 6b) .
Dual BFP switch assay. The switch assay uses the dBFP to analyse the crosstalk between cell surface receptors, as recently described 9, 20 . The dBFP set-up has two probes on one side for the same platelet to contact sequentially. The platelet was first aligned to probe I coated with VWF A1 (Fig. 2a) and tested by repeated cycles in force-clamp mode at 25 pN. Once a lifetime event of any duration (Fig. 5b,c) or >2 s was observed, the platelet-aspirating micropipette was manually switched (duration within <30 s or as specified) to align with probe II coated with FN, Fg or an anti-α IIb β 3 mAb (Fig. 2b) depending on whether the experimental objective was to measure ligand binding or conformation or the activation state of α IIb β 3 . The force-ramp or -clamp mode was used depending on whether the desired type of assay was adhesion frequency or bond lifetime.
Fluorescence BFP assay for concurrent intracellular Ca 2+ imaging. We used fBFP to quantify the intraplatelet Ca 2+ level induced by GPIbα mechanosignalling or agonist receptor signalling, as previously described 13, 65 . All results were obtained from n ≥ 3 independent experiments in duplicates.
We pre-incubated platelets with Fura2-AM and analysed one platelet at a time by concurrent force spectroscopy and Ca 2+ imaging for a continuous period of 200 s. The force spectroscopic assays were done in either force-ramp or forceclamp mode using either a single force probe or dual force probes 20 . Calcium was measured using ratiometric imaging with a light source that alternates two excitation wavelengths, 340 and 380 nm, to excite Ca 2+ -bound and Ca
2+
-free Fura2, respectively. The two emission lights were captured by a fluorescence camera 13, 65 . The real-time intracellular Ca 2+ level over the 200 s observation time was quantified by the ratio of the emissions excited by the 340 and 380 nm channels collected by the software Micromanager (version 1.4), which was normalized by the initial value.
The Ca 2+ time curve was quantified by two parameters: maximum Ca ).
Molecular stiffness measurement. As previously described 35 , the stiffness of a single integrin-ligand complex was measured by the stretch method using the ramp phase data of the BFP experiment ( Supplementary Fig. 5a ). The force versus time data were transformed using the displacement versus time data, which were read from the capacitive strain sensor of the piezoelectric translator that drove the platelet-holding micropipette. The resulting force versus displacement data were fit to two line segments with a kink at the zero force point ( Supplementary  Fig. 9b ). The slope of the compressive segment (force < 0) reflects the stiffness of the platelet, denoted by a spring constant k plt (Supplementary Fig. 9c ). The slope of the tensile segment (force > 0) reflects the stiffness of the platelet and the ligand-ligand complex in series, denoted by an equivalent spring constant k eq . The molecular stiffness, denoted by a spring constant k mol , can be calculated as Supplementary Fig. 9c ). The k mol value mainly reflects the integrin stiffness as the contribution from FN is negligible.
To measure integrin stiffness, probe II of dBFP was coated with FN with a titrated density to ensure infrequent adhesion (≤20%) under each condition. To measure the stiffness of α IIb β 3 , mAb LM609 was added to block α V β 3 binding. To measure the stiffness of α V β 3 , mAb 10E5 was added to block α IIb β 3 binding. In control experiments, integrilin was added to test binding specificity, which eliminated almost all adhesion events under all conditions, indicating no contribution from α 5 β 1 binding.
Similar to the control experiments performed for lifetime measurements, to exclude the possibility of multimeric bonds between up to four FN molecules captured by SA and potential α IIb β 3 clusters, molecular stiffness was also measured with mutant monovalent SA, which rendered no significant difference ( Supplementary Fig. 9d ). This again indicated that the multimeric-bond effect was negligible using the WT SA.
Molecular site density measurement. We used flow cytometry to measure the receptor and ligand site densities on platelets and BFP beads, respectively, as previously described 36 . Platelets were incubated with an FITC-conjugated HIP8 at 10 μg ml −1 at room temperature for 30 min for α IIb β 3 site density (m r ) measurements, or incubated first with LM609 at 10 μg ml −1 for 30 min and then PE-conjugated anti-mouse antibody for 30 min for α V β 3 m r measurements. The m r values were measured using conformation-independent mAbs, hence including all conformers. The FN-and Fg-coated beads were incubated first with HFN 7.1 and 1D6 (Santa Cruz Biotechnology), respectively, and then with a PE-conjugated polyclonal antimouse antibody. The fluorescent intensities of the cells or beads were measured using a BD LSR flow cytometer (BD Biosciences) and compared to standard calibration beads (Bangs Laboratories) to determine the number of molecules per cell/bead. The site density was calculated by dividing the total number of molecules per cell/bead by the cell/bead surface area 36 , which was calculated from the radii measured with a customized Labview (National Instrument) program.
Calculation of average affinity. For biomolecular interaction between two molecular species, the equilibrium adhesion frequency can be related to the average number of receptor-ligand bonds by <n> = −ln(1 -P a ) = m r m l A c K a based on our published model 36 , where m r and m l are the respective site densities of the receptors (measured using conformation-independent mAbs) and ligands (measured by immunostaining and flow cytometry), A c is the contact area and K a is the affinity in µm 2 . However, platelets express three FN-binding integrins. Also, different copies of the same integrin may exist in different affinity states. Therefore, the average number of total bonds is <n> total = <n> 1 + <n> 2 + … if the concurrent interactions of different species are independent, where <n> i = m r,i m l,i A c K a,i is the average number of bonds of the ith molecular species expressed in terms of their site densities and affinity 66 . For example, the α IIb β 3 site density m r on ADP-activated platelets included three fractions (f i = m r,i /m r , i = 1-3) with low (K a,1 ), intermediate (K a,2 ) and high (K a,3 ) affinities for FN, coated on the BFP bead at site density m l . The adhesion frequency assay measures an average affinity that is equal to the sum of the three affinities weighted by the three α IIb β 3 fractions: Note that, when calculating <n> (Fig. 3b) and <A c K a > (Fig. 3c,f) , binding of the FN beads used in Fig. 3a was too low under certain conditions, which could overestimate the results. To allow accurate calculation, we repeated the experiments using beads with a higher FN coating density (3× FN beads) to ensure that the adhesion frequency would reach a reasonable level (~20%) and contain mostly specific binding.
Cone-and-plate shear assay. Isolated human platelets in Tyrode buffer (50 × 10 6 ml −1
) were gently incubated with dA1 (2 μg ml
) and the desired α IIb β 3 conformation reporter mAbs (1 μg ml ) in 100 µl Tyrode buffer were stimulated with ADP (0-10 µM) for 10 min in the presence of the desired α IIb β 3 reporter mAbs (1 μg ml
−1
). Platelets were then diluted 10 times to stop the reaction and immediately analysed by flow cytometry. The percentage of positive population and fluorescent intensities (Geomean) were analysed using FlowJo software (FlowJo LLC). By default, the gate was set around the 2% position in the fluorescence intensity histogram of the corresponding isotype control.
Parallel flow chamber experiments using microfluidic devices. Single-zone set-up. Microfluidic devices were uniformly coated with a solution of one or a mixture of two proteins (A1 and/or FN, 100 μg ml −1 each) for 1 h. The coated area is named the 'reporting' zone.
Multi-zone set-up. The multi-zone device separated the ligand interaction with platelet GPIbα and integrin α IIb β 3 in space and time. In the devices, the flow chamber floor was divided into multiple functional zones, which were fabricated to register sequentially 67 . Platelets were perfused at 4 dynes cm −2 to sequentially encounter each zone with spatiotemporal control, including zones A, B and C (Fig. 5d) . Coating of the three zones was nearly seamless, leaving no gap between adjacent zones. Zone A was 800 μm long and coated with 100 μg ml −1 FN for 1 h. Zone B had a variable length of 50-800 μm and was coated with 100 μg ml −1 A1 for 1 h. Zone C was 800 μm long and was coated with 100 μg ml −1 of one of the α IIb β 3 reporter mAbs for 1 h. ) were perfused through the devices, and the number of adherent platelets per unit area in the reporting zone was counted on two random fields of view after 2 min of continuous flow. Each condition was repeated in three devices for each sample. For conditions that required ADP activation, the platelet suspension was pre-incubated with ADP of varying concentrations (0.01, 0.1, 1 and 10 μM) for 15 min before perfusing through the devices.
Statistical analysis.
For most experiments, statistical significance was assessed by two-tailed Student's t-test (statistics are summarized in Supplementary Table 2) .
For comparisons of the goodness of fit between single-, dual-and tripleGaussian fits for the stiffness histograms, the extra sum-of-squares F test (Supplementary Table 1a ) and Akaike's information criteria (Supplementary  Table 1b ) were used.
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Recruitment
After the notice was sent out, the first volunteer that responded was always chosen as the blood donor. No bias of selection can be envisioned. All participants and their accompanying guardians were provided with a verbal explanation of the study. A verbal agreement and a signed consent form were respectively collected from the participants and accompanying guardians, stating that they agree for blood donation, and for the publication of the data collected using their blood.
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Methodology Sample preparation
Details of platelets isolation from whole blood was described in the Methods section of the paper. Once the platelet suspension was prepared, it was stained by FITC-conjugated HIP-8 at 10 μg mL-1 at room temperature for 30 min and then tested by flow cytometry. The FN and Fg coated beads were incubated first with HFN 7.1 and 1D6, respectively, and then with a PE-conjugated polyclonal anti-mouse antibody. For integrin conformation assays, isolated platelets in Tyrode's buffer were stimulated either by agonist or shear stress in the presence of Alexa 488-conjugated integrin antibodies before subject to flow cytometry.
Instrument
BD Biosciences BD LSR II; BD Accuri™ C6
